Vanguard Group Inc Capricor Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,305,078 shares of CAPR stock, worth $18.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,305,078
Previous 2,263,991
1.81%
Holding current value
$18.5 Million
Previous $21.5 Million
6.53%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CAPR
# of Institutions
139Shares Held
12.3MCall Options Held
4.98MPut Options Held
5.48M-
Black Rock Inc. New York, NY1.63MShares$13.1 Million0.0% of portfolio
-
State Street Corp Boston, MA1.47MShares$11.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA963KShares$7.74 Million0.0% of portfolio
-
Morgan Stanley New York, NY551KShares$4.43 Million0.0% of portfolio
-
Ubs Group Ag549KShares$4.42 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $196M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...